| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/23/2003 | CN1430966A Medicine combination contg. effective part of astragalus root |
| 07/23/2003 | CN1430965A Soft capsule of puerarin and preparing method thereof |
| 07/23/2003 | CN1430964A Extractive preparation containing total alkali of mulberry leaves and its preparing method |
| 07/23/2003 | CN1430963A Slowly releasing tablet of ligustrazine of phosphoric acid and its preparing method |
| 07/23/2003 | CN1430962A Skin liniment |
| 07/23/2003 | CN1430961A Compound of ceferamet used for injection |
| 07/23/2003 | CN1430960A Central nerve antalgic preparation through nasal cavity administration |
| 07/23/2003 | CN1430959A Compsn. contg. 5-[4-[2-(N-methyl-N-2-pyridyl) amino-) oxethyl] beazyl] thiazolidine-2,4-tetraethyldiaminobenzophenone |
| 07/23/2003 | CN1430958A Liniment of levamisole hydrochloride |
| 07/23/2003 | CN1430957A Application of alpha benzyl, beta benzyl and gamma butyrolactone for preparing medicine of lowering blood sugar |
| 07/23/2003 | CN1430956A Medicine for treating intestinal tract disease |
| 07/23/2003 | CN1430954A Soft capsule in total flavone of hawthorn leaves and its preparing method |
| 07/23/2003 | CN1430952A Asiaticoside liposome and its use |
| 07/23/2003 | CN1115414C Virus carrier used for gene therapy |
| 07/23/2003 | CN1115345C Carbohydrate derivatives |
| 07/23/2003 | CN1115342C Hypnotic beta-carboline derivatives, process for their prepn. and their use as medicinal products |
| 07/23/2003 | CN1115341C Substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases |
| 07/23/2003 | CN1115339C Novel sulfonylaminopyrimidines |
| 07/23/2003 | CN1115336C 1-phenyl-benzimidazole compounds and their use as BAGA-A receptor modulator |
| 07/23/2003 | CN1115334C Pyridine derivative and pharmaceutical contg. same |
| 07/23/2003 | CN1115330C N-(4-carbamimido-phenyl)-phenylglycinamid derivatives |
| 07/23/2003 | CN1115320C Process for synthesizing ketoibuprofen |
| 07/23/2003 | CN1115161C Aitonging plaster for treating cancer and its prepn. method |
| 07/23/2003 | CN1115155C Sobering-up beverage and its prepn. method |
| 07/23/2003 | CN1115154C Piles medicine |
| 07/23/2003 | CN1115153C Medicine synergist |
| 07/23/2003 | CN1115152C Method for treating bronchitis with uridine triphosphates and related compounds |
| 07/23/2003 | CN1115151C Mixture of vasodilating agents and medical diluet or carrier in prepn. of medicine for treating liver disease |
| 07/23/2003 | CN1115150C Pharmaceutical compsns. contg. ibuprofen and domperidone for treatment of migraine |
| 07/23/2003 | CN1115149C Aqueous process for mfg. paroxetine solid dispersions |
| 07/23/2003 | CN1115148C Skin penetration enhancing components |
| 07/23/2003 | CN1115147C Improved method for preparing potassium clavulanate |
| 07/23/2003 | CN1115146C Use of rifaximin in treatment of diarrhoea from cryptosporidiosis |
| 07/23/2003 | CN1115145C Improving tolerability of pharmaceutically active beta-amino acids |
| 07/23/2003 | CN1115141C In-situ generation of zinc pyrithione |
| 07/22/2003 | USRE38200 Indole-2,3-dione-3-oxime derivatives |
| 07/22/2003 | US6596907 Halogenating alkoxyphenol; reacting with p-dihalobenzene in presence of copper or salt; etherification; ether fission |
| 07/22/2003 | US6596900 Brain, nervous system, neurodegenerative, gastrointestinal, sleep, rheumatic, and psychological disorders; analgesics, antiepileptic agents |
| 07/22/2003 | US6596886 Method for producing a non-fatty softener based on wax-esters |
| 07/22/2003 | US6596885 19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions |
| 07/22/2003 | US6596878 Protein kinase inhibitor compositio; used to treat cell proliferative disorders such as cancers charcterized by over-activity or inappropriate activity HER2 or EGFR. |
| 07/22/2003 | US6596874 Salt formation by reaction using benzenesulfonic acid |
| 07/22/2003 | US6596869 Reacting cyanoquinuclidine compound with isoamyl nitrite for nitrosation |
| 07/22/2003 | US6596867 Bone disorders |
| 07/22/2003 | US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 07/22/2003 | US6596851 Antibody for use in the treatment of cell proliferative disorders |
| 07/22/2003 | US6596845 Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agents |
| 07/22/2003 | US6596791 Polymer complexes of glucuronoglucanes |
| 07/22/2003 | US6596774 For their ability to inhibit the growth of human oral epidermoid carcinoma cells, human cervical carcinoma cells and Chinese hamster ovary cells |
| 07/22/2003 | US6596773 Central nervous system disorders |
| 07/22/2003 | US6596772 Relates to trifluoromethyl sulfonyl and trifluoromethyl sulfonamido compounds and the physiologically acceptable salts and the prodrugs thereof. These compounds are expected to modulate the activity of protein tyrosine enzymes which are |
| 07/22/2003 | US6596770 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 07/22/2003 | US6596769 20-Hete antagonists and agonists |
| 07/22/2003 | US6596768 Unsaturated lipid-enriched feedstock for ruminants |
| 07/22/2003 | US6596767 Adjustment of fat concentration |
| 07/22/2003 | US6596766 Method for relieving arachidonic acid deficient conditions and maintaining a good fatty acid balance in vivo in mammals excluding humans, comprising the process of administering 4, 7, 10, 13, 16-docosapentaenoic acid (DPA)-containing material |
| 07/22/2003 | US6596765 Treatment of ocular hypertension and glaucoma |
| 07/22/2003 | US6596764 Method of preparing diacetyl rhein |
| 07/22/2003 | US6596763 Method for counteracting infections caused by bacteria, fungi or virus such as Herpes Simplex Virus in skin or mucosal membranes, in particular genital membranes, of a mammal. The method comprises topically administering to skin or mucous |
| 07/22/2003 | US6596762 Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis |
| 07/22/2003 | US6596761 Cosmetic and dermatological preparation with flavonoids |
| 07/22/2003 | US6596759 Medicament for treatment of irritable bowel syndrome |
| 07/22/2003 | US6596758 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
| 07/22/2003 | US6596757 Taxanes linked to a cell binding agent. A therapeutic composition for killing selected cell populations comprising: (A) a cytotoxic amount of one or more polyethylene glycol-containing taxanes covalently bonded to a cell binding |
| 07/22/2003 | US6596756 Treatment of fibromyalgia |
| 07/22/2003 | US6596755 An oral formulation comprising an imino acid conjugate of methylglyoxal of Structure (I) treating cancer of the lung, colon, pancreas, oral, prostate, glioblastoma or lukemia comprising administering a formulation of an imino acid |
| 07/22/2003 | US6596754 Preventives/remedies for multiple organ failure |
| 07/22/2003 | US6596753 Compounds of the indolecarboxylic family and use thereof |
| 07/22/2003 | US6596752 Inhibitors of α4β1 mediated cell adhesion |
| 07/22/2003 | US6596751 α-substituted carboxylic acid derivatives |
| 07/22/2003 | US6596750 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 07/22/2003 | US6596749 Neuropeptide y receptor ligand |
| 07/22/2003 | US6596746 Cyclic protein tyrosine kinase inhibitors |
| 07/22/2003 | US6596745 Method for treating fibrotic diseases with azolium chroman compounds |
| 07/22/2003 | US6596744 Method for treating fibrotic diseases or other indications IIC |
| 07/22/2003 | US6596743 Carbamic acid derivatives |
| 07/22/2003 | US6596742 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use in medicaments |
| 07/22/2003 | US6596740 Nicotine mucosal spray |
| 07/22/2003 | US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): |
| 07/22/2003 | US6596737 C10 carbamoyloxy substituted taxanes |
| 07/22/2003 | US6596736 Well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non- toxic therapeutically effective amount of a compound of Formula I. pain, dysmenorrhea, myositis, |
| 07/22/2003 | US6596735 Compounds and to the use of said compounds for inhibiting abnormal cell growth in mammals. The compounds of the above formula have activity as farnesyl protein transferase inhibitors. for treatment of cancer andhyperproliferation |
| 07/22/2003 | US6596733 Nitric oxide scavengers, such as dithiocarbamate-containing compounds, are used to reduce side effects caused by therapeutical administration of nitric oxide sources |
| 07/22/2003 | US6596732 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 07/22/2003 | US6596731 Substituted imidazo[1,2-A] pyridine derivatives |
| 07/22/2003 | US6596730 Phenyl urea and phenyl thiourea derivatives |
| 07/22/2003 | US6596729 Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors |
| 07/22/2003 | US6596728 A pharmaceutical composition, comprising at least one compound or salt thereof as claimed in claim 1 and a polypeptides with excipients |
| 07/22/2003 | US6596726 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme |
| 07/22/2003 | US6596725 Vision defects |
| 07/22/2003 | US6596723 Fungal efflux pump inhibitors |
| 07/22/2003 | US6596722 Serotonin reuptake inhibitors/HT3 receptor antagonists useful for treatment of depression, psychosis, anxiety disorders, panic disorder, obsessive compulsive disorder, and eating disorders |
| 07/22/2003 | US6596721 (6S)- or 10 (6R,S)- tetrahydrofolic acid is crystallized in a polar medium with pH of 3.5 or greater and have a purity 98% |
| 07/22/2003 | US6596720 Potentiating an anti-HIV activity of trifluridine and derivatives in thereof in a mammal, including human, comprising administering to said mammal, including human, an effective amount of a thymidine phosphorylase inhibitor and |
| 07/22/2003 | US6596719 6 alkoxy-4-pyrimidinyl bis-sulfonamides |
| 07/22/2003 | US6596718 7-Morpholin-4yl-benzothiazole amide derivatives |
| 07/22/2003 | US6596716 2-propane-sulphonamide derivatives |
| 07/22/2003 | US6596715 Protease inhibitors |
| 07/22/2003 | US6596714 parasiticidal formulation for oral administration, comprising the mixture of: edible, non-aqueous liquid; thickening agent; agent effective against nematodes and obligate parasitic flies; and cestocidal agent, wherein said cestocidal agent is |
| 07/22/2003 | US6596712 Administering an effective amount of cytotoxic chemical compound selected from nitrosourea, cyclophophamide, doxorubicin, 5-fluorouracil, cisplatin etc. in first treatment of cancer and squalamine in second treatment step |